Trial Profile
Clinical Trials Insight: 700037567
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 30 Sep 2008
Price :
$35
*
At a glance
- Drugs Encaleret (Primary)
- Indications Osteoporosis
- Focus Adverse reactions
- Sponsors Merck & Co
- 30 Sep 2008 New trial record.